Skip to main content
In-Vitro Research Only
Sign in

CJC-1295 No DAC (Mod GRF 1-29) | 2mg, 5mg & 10mg

CJC-1295 No DAC (Mod GRF 1-29) | 2mg, 5mg & 10mg
SKU:
CJC-1295-ND
Calculating active researchers...
From €15.61
Adding to cart… The item has been added
International Tracked (5-10 Days)

AT A GLANCE Β· KEY RESEARCH SUMMARY
Primary Focus
Pulsatile Growth Factor Signalling
Popular Stack Partner
Ipamorelin and the Tesamorelin Bundle
Fridge Storage
2Β°C–8Β°C Standard Fridge (12–24 Months)
Quality Standard
99%+ HPLC Verified Β· Instant COA & Spec
  • CJC-1295 without DAC is studied for a short, pulsatile growth-hormone signal rather than a release that stays elevated all day.
  • Studies describe a brief GHRH-receptor pulse. It is usually discussed with a ghrelin mimetic such as Ipamorelin so the two signals rise together.
  • Mix the freeze-dried cake with bacteriostatic reconstitution solution (0.9% benzyl alcohol), keeping the stream off the powder. Unmixed vials keep for 12 to 24 months in a standard household fridge at 2Β°C–8Β°C, and the mixed vial stays in that same fridge.
What is CJC-1295 No DAC (Mod GRF 1-29)?

CJC-1295 No DAC, frequently referred to as Modified GRF (1-29), is a synthetic analogue of endogenous growth hormone-releasing hormone (GHRH). In cellular models, this tetrasubstituted peptide demonstrates enhanced resistance to enzymatic cleavage compared to its natural counterpart. As a premium research chemical, UK laboratories utilise this compound to investigate receptor-ligand interactions and intracellular signalling cascades. The structural modifications introduced during advanced peptide synthesis significantly improve its molecular stability, allowing researchers to observe prolonged receptor activation in vitro. When preparing laboratory stocks, precise reconstitution protocols must be followed to maintain the structural integrity of the lyophilised solid. By binding to GHRH receptors on target cells, it triggers the cAMP-dependent pathway, which is a primary focus in contemporary biochemical studies. For deeper insights into structural variations, researchers often explore the Cjc 1295 With Dac Vs No Dac Understanding Half Life Differences to optimise experimental timelines. Further structural data and related analogue properties can be reviewed on PubChem.

FREQUENTLY STACKED TOGETHER
Published stacks place these bundles, blends, and the matching solvent beside this compound.
Research FAQ
What are the benefits of Mod GRF 1-29?
Public search data clusters around the term "benefits" when indexing this peptide. Published papers describe these effects strictly in terms of receptor binding affinity in isolated cell cultures, not as a consumer protocol. Amino Peptides supplies this compound only as a lyophilised laboratory reagent. Strictly for laboratory research.
What are the benefits of taking CJC-1295 without DAC?
Current literature uses the search phrase "benefits of taking" when categorising B2C queries. Research trends summarise those papers as observations in controlled molecular experiments, not as a bodily protocol. Amino Peptides supplies this compound only as a lyophilised laboratory reagent. Strictly for laboratory research.
How long to start seeing results with CJC -/ 1295 DAC?
Research trends often mention the phrase "seeing results" in public search data. Current literature on this reagent is centred on cellular binding kinetics and half-life measurements in lab models, rather than human outcomes. Amino Peptides supplies this compound only as a lyophilised laboratory reagent. Strictly for laboratory research.
What are the downsides of CJC-1295?
Published studies discussed under this heading often note the word "downsides" when evaluating molecular stability. These texts focus on peptide degradation rates in cell-free environments rather than side effects in subjects. Amino Peptides supplies this compound only as a lyophilised laboratory reagent. Strictly for laboratory research.
Does CJC mess with testosterone?
Public search data clusters around the phrase "mess with testosterone" regarding hormonal pathways. Laboratory experiments investigate these interactions exclusively in isolated endocrine cell models to map receptor cascades. Amino Peptides supplies this compound only as a lyophilised laboratory reagent. Strictly for laboratory research.
How should I store this peptide?
Unmixed freeze-dried (lyophilised) vials remain stable at ambient room temperature during postal transit and can be stored in a standard refrigerator (2–8Β°C) away from light for 12 to 24 months. Once reconstituted with Bacteriostatic Reconstitution Solution (0.9% benzyl alcohol), keep refrigerated at 2–8Β°C and do not freeze.
Laboratory Authority Record

Public search data clusters around B2C queries when discussing this peptide. Current literature uses these search phrases to index laboratory cell-repair models, not consumer protocols. Research trends summarise those papers as observations in isolated cell cultures. Amino Peptides supplies this compound only as a lyophilised laboratory reagent strictly for laboratory research.

Target Receptors
  • Selective binding to the growth hormone secretagogue receptor (GHS-R1a) in isolated somatotroph cell models.
  • Interaction with anterior pituitary receptor complexes to evaluate binding affinity and receptor internalisation.
  • Modulation of G-protein coupled receptor (GPCR) conformations in cell-free membrane preparations.
  • Evaluation of ligand-receptor dissociation rates compared to endogenous GHRH analogues.
Mechanisms of Action
  • Activation of the adenylyl cyclase pathway, leading to elevated intracellular cyclic AMP (cAMP) levels in laboratory cell cultures.
  • Stimulation of protein kinase A (PKA) cascades, measured through phosphorylation studies in controlled environments.
  • Induction of calcium ion influx via voltage-gated calcium channels in isolated cellular frameworks.
  • Assessment of proteolytic cleavage resistance in cell-free stability experiments.

Technical Specifications

CAS
863288-34-0
MOLECULAR FORMULA
C152H252N44O42
MOLECULAR WEIGHT
3367.9 g/mol
SEQUENCE
YADAIFTQSYRKVLAQLSARKLLQDILSR
PURITY
>99% (HPLC Verified)
APPEARANCE
Lyophilised Solid
TARGET RECEPTOR
GHRH Receptor (GHRHR)
CHEMICAL NAME
Tetrasubstituted Growth Hormone-Releasing Factor (1-29)
RECOMMENDED SOLVENT
Bacteriostatic Reconstitution Solution

Variant Breakdown

  • 2mg Vial: Ideal for preliminary in-vitro assays requiring small-scale stock solutions and immediate cellular application.
  • 5mg Vial: Suited for medium-throughput screening and extended receptor binding studies, offering a balanced quantity for multiple experimental runs.
  • 10mg Vial: Designed for comprehensive, longitudinal cellular models and extensive biochemical profiling where consistent batch continuity is essential.

Quality Assurance

  • HPLC Analysis: High-performance liquid chromatography is utilised to confirm a purity level exceeding 99%, ensuring the absence of truncated sequences.
  • Mass Spectrometry: Molecular weight is precisely verified using mass spectrometry, confirming the exact tetrasubstituted structural identity.
  • Lyophilised Form: The compound is supplied as a stable, lyophilised solid to preserve molecular integrity during transit and long-term storage.
  • Laboratory Characterisation: Each batch undergoes rigorous endotoxin testing and solubility profiling to guarantee suitability for sensitive in-vitro environments.

Research Mechanism

  • Receptor Binding: The peptide selectively binds to the GHRH receptor (GHRHR), a G-protein coupled receptor located on the surface of specific target cells.
  • Signal Transduction: Upon binding, it induces a conformational change that activates the stimulatory G-protein (Gs), leading to the upregulation of adenylate cyclase.
  • cAMP Elevation: Adenylate cyclase catalyses the conversion of ATP to cyclic AMP (cAMP), significantly raising intracellular secondary messenger levels.
  • Kinase Activation: Elevated cAMP activates Protein Kinase A (PKA), which subsequently phosphorylates downstream target proteins and transcription factors.
  • Enzymatic Resistance: The substitution of four specific amino acids prevents rapid degradation by dipeptidyl peptidase-4 (DPP-4), extending the duration of receptor activation in culture.

Reconstitution & Storage Data

Vial StrengthSolvent AddedResulting Concentration
2mg1 mL Bacteriostatic Reconstitution Solution2.00 mg/mL
2mg2 mL Bacteriostatic Reconstitution Solution1.00 mg/mL
5mg1 mL Bacteriostatic Reconstitution Solution5.00 mg/mL
5mg2 mL Bacteriostatic Reconstitution Solution2.50 mg/mL
10mg1 mL Bacteriostatic Reconstitution Solution10.00 mg/mL
10mg2 mL Bacteriostatic Reconstitution Solution5.00 mg/mL
Storage Guidelines
  • Lyophilised (Freeze-Dried Vial): Stable at ambient room temperature during postal transit; store in a standard refrigerator (2–8Β°C) away from direct light for 12–24 months.
  • Reconstituted (Liquid Solution): Store refrigerated at 2–8Β°C away from light. Using sterile bacteriostatic reconstitution solution (0.9% benzyl alcohol) preserves sterility across multiple draws while refrigeration maintains peptide integrity. Do not refreeze once mixed.

Scientific References

Endocrinology: "Structure-activity relationships of growth hormone-releasing factor analogues" View Study

Molecular Endocrinology: "Signal transduction mechanisms of the growth hormone-releasing hormone receptor" View Study

Journal of Peptide Research: "In vitro stability and enzymatic degradation of GHRH analogues" View Study

Biochemical Journal: "Dipeptidyl peptidase IV cleavage of growth hormone-releasing hormone" View Study

Peptides: "Conformational analysis and receptor binding of modified GRF peptides" View Study

Recently Viewed

loading

 

 
loading

 

 
loading